Trial Outcomes & Findings for Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells (NCT NCT02617888)

NCT ID: NCT02617888

Last Updated: 2017-07-11

Results Overview

The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

228 participants

Primary outcome timeframe

Change from baseline double strand DNA breaks at 30 minutes post-imaging

Results posted on

2017-07-11

Participant Flow

101 patients enrolled in intervention arms (breast shields). Other patients in observational arm (not completed analysis).

Participant milestones

Participant milestones
Measure
CCTA Breast Shields
Within female subset, randomization to wearing bismuth breast shield. .
CCTA No Breast Shields
Within female subset, randomization to not wearing bismuth breast shield (standard of care).
Observational
Non-female patients undergoing coronary CTA, patients undergoing nuclear cardiology studies and invasive coronary angiography.
Overall Study
STARTED
50
51
127
Overall Study
COMPLETED
49
44
127
Overall Study
NOT COMPLETED
1
7
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CCTA Breast Shields
n=50 Participants
Within female subset, randomization to wearing bismuth breast shield.
CCTA No Breast Shields
n=51 Participants
Within female subset, randomization to not wearing bismuth breast shield (standard of care).
Observational Arm
n=127 Participants
1\. Non-female patients undergoing coronary CTA; 2. Patients undergoing nuclear cardiology stress testing; 3. Patients undergoing invasive coronary angiography.
Total
n=228 Participants
Total of all reporting groups
Age, Continuous
52 years
STANDARD_DEVIATION 14 • n=5 Participants
51 years
STANDARD_DEVIATION 14 • n=7 Participants
51 years
STANDARD_DEVIATION 12 • n=5 Participants
52 years
STANDARD_DEVIATION 14 • n=4 Participants
Sex: Female, Male
Female
50 Participants
n=5 Participants
51 Participants
n=7 Participants
92 Participants
n=5 Participants
193 Participants
n=4 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
35 Participants
n=5 Participants
35 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
14 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
46 Participants
n=5 Participants
48 Participants
n=7 Participants
115 Participants
n=5 Participants
209 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
5 Participants
n=5 Participants
5 Participants
n=4 Participants
BMI (kg/m^2)
27.6 kg/m^2
STANDARD_DEVIATION 6.3 • n=5 Participants
28.1 kg/m^2
STANDARD_DEVIATION 4.5 • n=7 Participants
27.3 kg/m^2
STANDARD_DEVIATION 5 • n=5 Participants
27.9 kg/m^2
STANDARD_DEVIATION 5.5 • n=4 Participants
Chest circumference (cm)
97.6 cm
STANDARD_DEVIATION 11.7 • n=5 Participants
97.8 cm
STANDARD_DEVIATION 10.5 • n=7 Participants
97.7 cm
STANDARD_DEVIATION 11 • n=5 Participants
97.7 cm
STANDARD_DEVIATION 11.1 • n=4 Participants
Current smokers
5 Participants
n=5 Participants
7 Participants
n=7 Participants
15 Participants
n=5 Participants
27 Participants
n=4 Participants
Heart rate (beats/min)
55.2 beats/min
STANDARD_DEVIATION 5.6 • n=5 Participants
56.2 beats/min
STANDARD_DEVIATION 7.4 • n=7 Participants
64 beats/min
STANDARD_DEVIATION 9 • n=5 Participants
55.7 beats/min
STANDARD_DEVIATION 6.6 • n=4 Participants

PRIMARY outcome

Timeframe: Change from baseline double strand DNA breaks at 30 minutes post-imaging

Population: Female patients 18 years or older who were clinically referred to undergo coronary CT angiography between August 2012 and July 2014 at Walter Reed National Military Medical Center (Bethesda, Maryland) were eligible for enrollment.

The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.

Outcome measures

Outcome measures
Measure
No Breast Shields
n=49 Participants
Within female subset, randomization to wearing bismuth breast shield or not wearing bismuth breast shield (standard of care). CCTA: Breast shield placement (randomized) among women.
Breast Shields
n=44 Participants
Within female subset, randomization to wearing bismuth breast shield or not wearing bismuth breast shield (standard of care). CCTA: Breast shield placement (randomized) among women.
Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging
0.183 gamma-H2AX foci in blood lymphocytes
Standard Deviation 0.114
0.159 gamma-H2AX foci in blood lymphocytes
Standard Deviation 0.139

Adverse Events

CCTA Breast Shields

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

CCTA No Breast Shields

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Observational Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Michael K. Cheezum, MD

Ft. Belvoir Community Hospital

Phone: 571-231-2159

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place